Physiologically based pharmacokinetic [PBPK] model for biodistribution of radiolabeled peptides in patients with neuroendocrine tumours
Asia Oceania Journal of Nuclear Medicine and Biology. 2016; 4 (2): 90-97
en Inglés
| IMEMR
| ID: emr-184712
ABSTRACT
Objective[s] The objectives of this work was to assess the benefits of the application of Physiologically Based Pharmacokinetic [PBPK] models in patients with different neuroendocrine tumours[NET] who were treated with Lu-177 DOTATATE. The model utilises clinical data on biodistribution of radiolabeled peptides [RLPs] obtained by whole body scintigraphy [WBS] of the patients
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Asia Oceania J. Nucl. Med. Biol.
Año:
2016
Similares
MEDLINE
...
LILACS
LIS